Description
PF-07104091 is a selective CDK2 inhibitor.
Product Unit Size | Cost | Quantity | Stock |
---|
PF-07104091 is a selective CDK2 inhibitor.
Cas No. | 2460249-19-6 |
---|---|
Purity | ≥98% |
Formula | C19H28N6O4 |
Formula Wt. | 404.47 |
IUPAC Name | [(1R,3S)-3-[3-[[5-(methoxymethyl)-2-methylpyrazole-3-carbonyl]amino]-1H-pyrazol-5-yl]cyclopentyl] N-propan-2-ylcarbamate |
Synonym | PF-07104091, PF 07104091, PF07104091, PF-7104091, PF 7104091, PF7104091 |
Appearance | White powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Synthetic ITC.
Fluoroquinolone; topoisomerase IV, topoisomeras...
Dopamine reuptake inhibitor (DRI).
Read-through agent and nonsense mutation target...
Endogenous peptide, cleavage product of AT II; ...
Endogenous peptide fragment, involved in vasoco...
Fluoroquinolone, S-(-) isomer of ofloxacin; top...
Tricyclic antidepressant; potential D1/2 antago...
Endogenous opioid peptide; μOR agonist.
Endogenous peptide hormone, involved in feeding...
Aminoglycoside; protein translation inhibitor.<...
PKA inhibitor.
Neuroactive mycotoxin produced by Penicillum an...
EGFR inhibitor.
GPR84 agonist.
Selective HDAC4 and HDAC5 inhibitor.
Statin; HMG-CoA reductase inhibitor.
Endogenous opioid peptide; μOR agonist.
Optically active isomer of ibuprofen, NSAID; CO...
Macrolide; protein synthesis inhibitor. ≥3900...